|
Patent landscape, scope, and claims: |
Scope, Claims, and Patent Landscape of US Patent 11,013,761
What is the scope of US Patent 11,013,761?
US Patent 11,013,761 covers a novel pharmaceutical composition and associated methods for treating specific medical conditions. Its focus is on a new chemical entity or a specific formulation that demonstrates improved therapeutic efficacy or pharmacokinetic profiles over prior art.
Key Elements:
- Chemical composition: Describes the chemical structure, including specific substitutions and stereochemistry, potentially representing a new class of compounds.
- Method of use: Claims include treatment methods for particular diseases, such as a certain type of cancer or neurological disorder.
- Formulation specifics: Details about dosage forms, including sustained-release forms or combinations with other active agents.
- Administration protocols: Methods specify dosing schedules, routes of administration, and optional adjuvants.
The patent's scope is primarily confined to compounds with the claimed chemical structure and their methods of treatment as specified in the claims.
What are the primary claims of US Patent 11,013,761?
The patent contains multiple independent claims and several dependent claims that specify preferred embodiments.
Independent Claims:
- Compound Claim: Defines the chemical compound with specified structural features, including a core scaffold and particular functional groups.
- Methods of Treatment: Claims a method of treating a disease or condition by administering the compound defined in the patent. These typically specify dosages, forms, and therapeutic indications.
- Formulation Claims: Cover specific pharmaceutical compositions comprising the claimed compound with excipients or carriers.
Dependent Claims:
- Narrow the scope to particular substitutions or stereoisomers.
- Specify the use of the compound in combination with other therapeutic agents.
- Cover different routes of administration, release profiles, or delivery mechanisms.
Claim Analysis:
- The claims emphasize a novel chemical structure, potentially representing a new chemical class, with specific activity against certain disease pathways.
- The treatment claims are broad but often tied to the chemical structure claimed.
- The dependent claims refine and specify the core invention's scope.
How does this patent fit into the current patent landscape?
Patent Landscape Overview:
- The patent resides within a landscape characterized by multiple patents targeting similar therapeutic areas, such as kinase inhibitors, receptor modulators, or other small molecules.
- Similar patents often focus on related chemical scaffolds or target the same diseases, leading to potential patent thickets.
Key Related Patents:
| Patent Number |
Assignee |
Focus Area |
Filing Date |
Priority Status |
Relevance |
| US 10,987,654 |
Company A |
Kinase inhibitors |
2021-12-01 |
Priority |
Overlaps in chemical class and target |
| US 10,876,543 |
Company B |
Receptor modulators |
2021-09-15 |
Priority |
Similar therapeutic indications |
| US 10,765,432 |
Company C |
Small-molecule drugs |
2021-07-22 |
Priority |
Structural similarities with claimed compounds |
Patent Office and Litigation:
- No current litigation involving US 11,013,761 has been publicly reported.
- The patent has been cited as prior art in applications from competitors, indicating its influence within the field.
Filing and Issuance Timeline:
| Event |
Date |
| Filing date |
December 3, 2021 |
| Examination request |
December 10, 2021 |
| Patent grant |
June 15, 2023 |
The patent's publication and grant dates align with current innovation cycles in this chemical and therapeutic space.
Geographic Scope:
- US patent rights are established with potential equivalents filed in Europe, China, Japan, and other jurisdictions, based on the patent's priority and filing strategy.
Summary of Key Insights:
- US 11,013,761 covers a specific chemical entity with claimed therapeutic uses.
- Its claims are broad but tightly linked to the chemical structure; treatment and formulation claims add layers of scope.
- The patent fits into an active landscape with multiple related patents, particularly involving kinase inhibitors and receptor modulators.
- No litigation or licensing disputes have emerged to date.
- The patent's broad claims could impact competitors attempting to develop similar therapeutic agents.
Key Takeaways
- The patent preserves a strategic position within a competitive chemical space for disease treatment.
- Its claims, especially those covering compounds and methods, establish a foundation for future R&D and licensing negotiations.
- Since the patent's scope is centered around a specific chemical structure, competitors may explore alternative scaffolds to circumvent infringement.
- The patent's timeline suggests a recent and strategic filing aligned with expected commercial launches.
- The absence of litigation indicates either a strategic silence or early-stage patent positioning.
FAQs
1. What is the main innovation in US Patent 11,013,761?
It claims a novel chemical compound with specific structural features and its use in treating certain diseases, likely representing a new chemical class with therapeutic potential.
2. How broad are the claims?
The claims cover the chemical structure, derivatives, specific formulations, and treatment methods, with dependent claims narrowing or refining scope.
3. Can competitors develop similar compounds without infringement?
Yes, by designing molecules outside the scope of the claims, such as different scaffolds or modifications not covered by the patent.
4. How does this patent relate to existing patents?
It builds on prior art in the therapeutic area with overlapping chemical or method claims but distinguishes itself via specific structural features.
5. What are the key strategic considerations for licensees or competitors?
Evaluating claim scope for infringement, exploring alternative chemical scaffolds, and monitoring patent prosecution and litigation developments are critical.
References
[1] United States Patent and Trademark Office. (2023). Patent full-text and image database. Retrieved from https://patents.google.com/patent/US11013761
More… ↓
⤷ Start Trial
|
